D. E. Shaw & Co., Inc. - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 75 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2022$522,000
+3.4%
982,916
+19.9%
0.00%
Q4 2021$505,000
-27.0%
819,506
+20.7%
0.00%
-100.0%
Q3 2021$692,000
-47.1%
678,716
-5.1%
0.00%0.0%
Q2 2021$1,309,000
+22.7%
715,435
+32.2%
0.00%0.0%
Q1 2021$1,067,000
-58.9%
541,302
-73.9%
0.00%
-50.0%
Q4 2020$2,593,000
-37.8%
2,074,154
-10.4%
0.00%
-50.0%
Q3 2020$4,168,000
-76.1%
2,315,488
+11.4%
0.00%
-81.0%
Q2 2020$17,437,000
+165.9%
2,078,342
+66.1%
0.02%
+110.0%
Q1 2020$6,557,000
+77.9%
1,251,270
+85.3%
0.01%
+150.0%
Q4 2019$3,686,000
+2.4%
675,153
-8.7%
0.00%0.0%
Q3 2019$3,600,000
-45.4%
739,110
-22.3%
0.00%
-50.0%
Q2 2019$6,592,000
-19.2%
951,134
-19.0%
0.01%
-27.3%
Q1 2019$8,163,000
+161.2%
1,174,551
+119.5%
0.01%
+175.0%
Q4 2018$3,125,000
+3620.2%
535,121
+4409.7%
0.00%
Q4 2017$84,000
-6.7%
11,866
-6.0%
0.00%
Q3 2017$90,00012,6260.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$6,307,0004.30%
ETF MANAGERS GROUP, LLC 8,103,641$10,130,0000.22%
AdvisorShares Investments LLC 271,873$340,0000.08%
Platform Technology Partners 60,000$75,0000.04%
PINNACLE ASSOCIATES LTD 942,079$1,178,0000.02%
HRT FINANCIAL LP 883,510$1,104,0000.02%
Virtu Financial LLC 153,908$192,0000.02%
Tekla Capital Management LLC 413,481$517,0000.02%
Aries Wealth Management 23,400$33,0000.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 56,932$71,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders